SRDX
🚫 does not pay dividends

Company News

Federal Judge Clears Path For GTCR's Takeover Of Surmodics After FTC Challenge
Benzinga • Vandana Singh • November 11, 2025

A federal court denied the FTC's request to block GTCR's $627 million acquisition of Surmodics, allowing the merger to proceed despite initial regulatory challenges related to medical device coating competition.

Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private
Benzinga • Anthony Noto • March 7, 2025

Raizen is exploring the sale of its Argentinian assets, Walgreens may go private in a $10 billion deal, and the U.S. government is considering acquiring TikTok's U.S. business amid a deadline. Meanwhile, Onsemi increased its bid for Allegro Microsystems, and American Express agreed to acquire Center.

Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research
GlobeNewswire Inc. • Allied Market Research • October 2, 2024

The biocompatible coating market is expected to grow significantly due to increased demand for medical implants and devices, advancements in nanotechnology, and rising prevalence of chronic diseases requiring medical interventions.

Down -5.46% in 4 Weeks, Here's Why SurModics Looks Ripe for a Turnaround
Benzinga • Zacks • September 5, 2024

SurModics (SRDX) has seen a 5.5% decline over the past four weeks, but its oversold RSI reading and improved earnings estimates suggest the stock could be due for a turnaround.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders - GlobeNewswire
GlobeNewswire Inc. • N/A • July 4, 2024

Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to the acquisitions of Alimera Sciences, Surmodics, and Atrion Corporation.

Related Companies